Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate whether treatment at standard doses with duloxetine (60 mg/day) in combination with pregabalin (300 mg/day) is superior to a maximal dose of duloxetine (120 mg/day) or pregabalin (600 mg/day) given as monotherapy, over an 8-week period, in patients with diabetic peripheral neuropathic pain, who don’t respond to a standard dose of either duloxetine or pregabalin after 8 weeks of initial treatment.
Critère d'inclusion
- diabetic peripheral neuropathic pain (DPNP)